SDC1 and Miyoshi myopathy: Moreover, heparan sulfate proteoglycans function as internalizing receptors of cancer cell-derived EVs, and their modification through antitumor action inhibits MM cell growth and angiogenesis via disruption of the heparanase/syndecan-1 (CD138) axis [30].